1085 related articles for article (PubMed ID: 15128354)
21. Risk of early surgery for Crohn's disease: implications for early treatment strategies.
Sands BE; Arsenault JE; Rosen MJ; Alsahli M; Bailen L; Banks P; Bensen S; Bousvaros A; Cave D; Cooley JS; Cooper HL; Edwards ST; Farrell RJ; Griffin MJ; Hay DW; John A; Lidofsky S; Olans LB; Peppercorn MA; Rothstein RI; Roy MA; Saletta MJ; Shah SA; Warner AS; Wolf JL; Vecchio J; Winter HS; Zawacki JK
Am J Gastroenterol; 2003 Dec; 98(12):2712-8. PubMed ID: 14687822
[TBL] [Abstract][Full Text] [Related]
22. Are complications of subtotal colectomy with ileorectal anastomosis related to the original disease?
Nakamura T; Pikarsky AJ; Potenti FM; Lau CW; Weiss EG; Nogueras JJ; Wexner SD
Am Surg; 2001 May; 67(5):417-20. PubMed ID: 11379639
[TBL] [Abstract][Full Text] [Related]
23. Infliximab for Crohn's disease in clinical practice: the experience of a single center in romania.
Gheorghe L; Gheorghe C; Badea M; Vădan R; Pârvulescu I; Toader C; Tugui L; Papuc O; Ionescu R; Preda C; Călin I; Diculescu M
Rom J Gastroenterol; 2003 Mar; 12(1):7-13. PubMed ID: 12673373
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study].
Doubremelle M; Bourreille A; Zerbib F; Heresbach D; Metman EH; Beau P; Gournay J; Galmiche JP
Gastroenterol Clin Biol; 2002 Nov; 26(11):973-9. PubMed ID: 12483127
[TBL] [Abstract][Full Text] [Related]
25. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
Rosenfeld G; Qian H; Bressler B
J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
[TBL] [Abstract][Full Text] [Related]
26. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
Baert F; Noman M; Vermeire S; Van Assche G; D' Haens G; Carbonez A; Rutgeerts P
N Engl J Med; 2003 Feb; 348(7):601-8. PubMed ID: 12584368
[TBL] [Abstract][Full Text] [Related]
27. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
[TBL] [Abstract][Full Text] [Related]
28. The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis.
Lim M; Sagar P; Abdulgader A; Thekkinkattil D; Burke D
Dis Colon Rectum; 2007 Jul; 50(7):943-51. PubMed ID: 17525860
[TBL] [Abstract][Full Text] [Related]
29. Review article: chronic active disease and maintaining remission in Crohn's disease.
Kamm MA
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience with infliximab therapy in 100 patients with Crohn's disease.
Farrell RJ; Shah SA; Lodhavia PJ; Alsahli M; Falchuk KR; Michetti P; Peppercorn MA
Am J Gastroenterol; 2000 Dec; 95(12):3490-7. PubMed ID: 11151882
[TBL] [Abstract][Full Text] [Related]
31. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
32. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
33. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
[TBL] [Abstract][Full Text] [Related]
34. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
Shental O; Tulchinsky H; Greenberg R; Klausner JM; Avital S
Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
Hlavaty T; Pierik M; Henckaerts L; Ferrante M; Joossens S; van Schuerbeek N; Noman M; Rutgeerts P; Vermeire S
Aliment Pharmacol Ther; 2005 Oct; 22(7):613-26. PubMed ID: 16181301
[TBL] [Abstract][Full Text] [Related]
36. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.
Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Langholff W; Londhe A; Sandborn WJ
Am J Gastroenterol; 2014 Feb; 109(2):212-23. PubMed ID: 24394749
[TBL] [Abstract][Full Text] [Related]
37. Infliximab: new preparation. A last resort for Crohn's disease.
Prescrire Int; 2000 Dec; 9(50):163-5. PubMed ID: 11475490
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease.
Uchino M; Ikeuchi H; Matsuoka H; Bando T; Ichiki K; Nakajima K; Tomita N; Takesue Y
Dis Colon Rectum; 2013 Oct; 56(10):1156-65. PubMed ID: 24022533
[TBL] [Abstract][Full Text] [Related]
39. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.
Ricart E; Panaccione R; Loftus EV; Tremaine WJ; Sandborn WJ
Am J Gastroenterol; 2001 Mar; 96(3):722-9. PubMed ID: 11280541
[TBL] [Abstract][Full Text] [Related]
40. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis.
Schaufler C; Lerer T; Campbell B; Weiss R; Cohen J; Sayej W; Hyams J
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):421-4. PubMed ID: 22395189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
